CEOs: Orthopedic implant demand to rebound with economy

Demand for orthopedic implants will remain under pressure until the economy improves and consumers have insurance again, Zimmer Holdings Chief Executive David Dvorak said at the J.P. Morgan Healthcare Conference in San Francisco. "There will continue to be an impact until unemployment rates are reduced and (insurance) enrollment rates go back up," Dvorak told investors in a presentation webcast. Report

Suggested Articles

The immunoassay will measure neurofilament light chain protein levels, found in the blood and cerebrospinal fluid, and linked to nerve damage.

Emmecell aims to make corneal transplant surgery, which can take up to a year to heal from and fails up to 20% of the time, a relic of the past.

Seven developers will provide digital health solutions aimed at the COVID-19 pandemic, including smartphone apps, wearables and big data programs.